Safety pharmacology of CKD-602, a novel anticancer agent

Arzneimittel-Forschung/Drug Research

Volumn 53, Issue 4, 2003, Pages 272-279

  Kim, Eun Joo ^a   Lee, Rae Kyong ^a   Suh, Jeong Eun ^a   Han, Sang Seop ^a   Kim, Joon Kyum ^b  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Jong Kun Dang Co   (South Korea)

Author keywords

Antitumor agent; Camptothecin derivative; CAS 213819 48 8; CKD 602, cardiovascular respiratory system, central nervous system, dog, general pharmacology, guinea pig, mouse, rat; Topoisomerase I inhibitor

Indexed keywords

7 [2 (N ISOPROPYLAMINO)ETHYL]CAMPTOTHECIN; ANTINEOPLASTIC AGENT; BELOTECAN; CAMPTOTHECIN DERIVATIVE; CAS 213819 48 8; DNA TOPOISOMERASE INHIBITOR; HEXOBARBITAL; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BREATHING RATE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CONVULSION; DRUG SAFETY; GASTROINTESTINAL MOTILITY; HYPERTHERMIA; LOCOMOTION; MOTOR COORDINATION; MOUSE; NONHUMAN; PYLORUS LIGATION; RAT; RESPIRATORY SYSTEM; SLEEP TIME; SMOOTH MUSCLE; STOMACH SECRETION; URINARY TRACT;

EID: 0038745984     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297108     Document Type: Article

References (15)

1. Wall, M. E., Wani, M. C., Cook, C. E. et al., Plant antitumors agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J. Am. Chem. Soc. 88, 3888 (1966)
2. Natelson, E. A., Giovauella, B. C., Verschraegen, C. F. et al., Phase I clinical and pharmacological studies of 20-(S)-camptothecin and 20-(S)-9-nitrocamptothecin as anticancer agents. Ann. NY Acad. Sci. 13, 803 (1996)
3. Shimada, Y., Yoshino, M., Wakuri, A. et al., Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer, CPT-11 Gastrointestinal cancer study group. J. Clin. Oncol. 11, 909 (1993)
4. Rowinsky, E. K., Grochow, L. B., Hendricks, C. B. et al., Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor. J. Clin. Oncol. 10, 647 (1992)
5. Kerrigan, J. E., Pilch, D. S., A structural model for the teruary cleavable complex forened between human topoisomerase I, DNA and Camptothecin. Biochemistry 33, 9792 (2001)
6. Guide for the care and use of laboratory animals, 7th Ed., Institute of laboratory animals resources commission on life science, National Research Council, National Academy Press, Washington D.C.
7. Irwin, S. I., Nodine, J. H., Siegler, P. E., Animal and clinical pharmacologic techniques in drug evaluation, pp. 36-54. Year-book Medical Publishers, Chicago (1964)
8. Svensson, T. H., Thieme, G., An investigation of a new instrument to measure motor activity of small animals. Psychopharmacologia (Berl.) 14, 157 (1969)
9. Dunham, W. W., Miya, T. S., A note on a simple apparatus of detecting neurological deficit in rats and mice. J. Am. Pharm. Ass. 10, 208 (1957)
10. Koster, R., Anderson, M., De Beer, E. J., Acetic acid for analgesic screening. Fed. Proc. 18, 412 (1959)
11. Woodbury, L. A., Davenport, V. D., Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern. Arch. Int. Pharmacodyn. 92, 97 (1952)
12. Swinyard, E. A., Brow, W. C., Goodman, L. S., Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. Exp. Ther. 106, 319 (1952)
13. Watts, J., Maiorano, L., Effects of diltiazem upon globally ischemic rat hearts. Eur. J. Pharmacol. 138, 335 (1987)
14. Bolli, R., Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc. Drugs Ther. 5, 249 (1991)
15. Shay, H., Komarov S. A., Fels S. S. et al., A simple method for the uniform production of gastric ulceration in rats. Gastroenterology 5, 43 (1945)